Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Human host factors required for influenza virus replication.

Nature | 2010

Influenza A virus is an RNA virus that encodes up to 11 proteins and this small coding capacity demands that the virus use the host cellular machinery for many aspects of its life cycle. Knowledge of these host cell requirements not only informs us of the molecular pathways exploited by the virus but also provides further targets that could be pursued for antiviral drug development. Here we use an integrative systems approach, based on genome-wide RNA interference screening, to identify 295 cellular cofactors required for early-stage influenza virus replication. Within this group, those involved in kinase-regulated signalling, ubiquitination and phosphatase activity are the most highly enriched, and 181 factors assemble into a highly significant host-pathogen interaction network. Moreover, 219 of the 295 factors were confirmed to be required for efficient wild-type influenza virus growth, and further analysis of a subset of genes showed 23 factors necessary for viral entry, including members of the vacuolar ATPase (vATPase) and COPI-protein families, fibroblast growth factor receptor (FGFR) proteins, and glycogen synthase kinase 3 (GSK3)-beta. Furthermore, 10 proteins were confirmed to be involved in post-entry steps of influenza virus replication. These include nuclear import components, proteases, and the calcium/calmodulin-dependent protein kinase (CaM kinase) IIbeta (CAMK2B). Notably, growth of swine-origin H1N1 influenza virus is also dependent on the identified host factors, and we show that small molecule inhibitors of several factors, including vATPase and CAMK2B, antagonize influenza virus replication.

Pubmed ID: 20027183 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: HHSN272200900032C
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI058113-010004
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007647-07
  • Agency: NIAID NIH HHS, United States
    Id: U54 AI057159
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI058113-020004
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007647-10
  • Agency: NIAID NIH HHS, United States
    Id: R21 AI083673
  • Agency: NIAID NIH HHS, United States
    Id: U54 AI057158
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI058113-050004
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007647-01
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007647-08
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI074539-01
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007647
  • Agency: NIAID NIH HHS, United States
    Id: 1F32AI081428
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007647-03
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI074539-02
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007647-02
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI1074539
  • Agency: NIAID NIH HHS, United States
    Id: 1R21AI083673
  • Agency: NCI NIH HHS, United States
    Id: 5R24 CA095823-04
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007647-05
  • Agency: NIAID NIH HHS, United States
    Id: F32 AI081428
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI058113-040004
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007647-06
  • Agency: NIAID NIH HHS, United States
    Id: U54 AI057158-065713
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI058113-030004
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007647-09
  • Agency: NIAID NIH HHS, United States
    Id: 1 P01 AI058113
  • Agency: NCRR NIH HHS, United States
    Id: 1 S10 RR0 9145-01
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI074539
  • Agency: NCI NIH HHS, United States
    Id: R24 CA095823
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007280
  • Agency: NIAID NIH HHS, United States
    Id: 1 T32 AI07647
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007647-04
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI074539-03
  • Agency: NIAID NIH HHS, United States
    Id: HHSN266200700010C
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI058113

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


A-549 (tool)

RRID:CVCL_0023

Cell line A-549 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MDCK (tool)

RRID:CVCL_0422

Cell line MDCK is a Spontaneously immortalized cell line with a species of origin Canis lupus familiaris

View all literature mentions

Vero (tool)

RRID:CVCL_0059

Cell line Vero is a Spontaneously immortalized cell line with a species of origin Chlorocebus sabaeus

View all literature mentions